$27.570
-1.241 (-4.50%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de IMNM por análisis de gráficos similares
Alphio's IMNM stock price prediction model matches the current Immunome Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $27.13 (-1.59%). The 1-week path is $28.40 (+3.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Immunome Inc?
Immunome Inc is a good buy right now due to its promising clinical data and strong cash position. The current price is $27.57, and analysts have set a price target of up to $37, indicating potential upside of 34%. Additionally, the company has a cash reserve of $582.7 million, which is expected to fund operations into 2028, mitigating short-term financial risks. However, the main risk is the negative net income, which stands at -$73.1 million for Q2 2026, indicating ongoing losses that investors should monitor closely.
IMNM cerró en $27.57 el Friday, tras bajar -4.50%
Immunome Inc (IMNM) last closed at $27.57, losing -4.50%. These facts feed the 1-day and 1-week IMNM price prediction above.
Factores de la previsión
Los factores de la previsión de Immunome Inc (IMNM) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de IMNM, ordenadas por similitud.
Análisis de estacionalidad de IMNM
Historically the probability of a positive August return for IMNM is 71.43%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.